why choose us

First received: September 09, 2022

Clinical Trial: A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Study Status: Completed

Recruit Status: RECRUITING

Condition: Overweight

Study Type: INTERVENTIONAL


Official Title: Tirzepatide Study of Renal Function in People With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes: Focus on Kidney Hypoxia in Relation to Fatty Kidney Disease Using M

Brief Summary: We are doing this study to learn more about how tirzepatide may help fight chronic kidney disease in people with obesity with or without type 2 diabetes (T2D).The study will last about 56 weeks and include up to 12 visits.

Read more